Topics

Latest "Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy" News Stories

00:37 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy for you to read. Along with our medical data and news we also list Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy Companies for you to search.

Showing "Comparison Lower risk Patients With Without Improvements Fatigue" News Articles 1–25 of 30,000+

Thursday 20th February 2020

Heart Transplant Rejection Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

Heart Transplant Rejection Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection Pipeline Review, H2 2019, provides an overview of the Heart Transplant Rejection Immunology pipeline landscape.Heart transplantation is the therapy used in various heart diseases. Heart transplant replaces an injured or diseased ...


Wednesday 19th February 2020

China reports 394 new cases of coronavirus, lowest since Jan. 23

Mainland China reported on Thursday the lowest number of confirmed cases of a new coronavirus since late January, partly due to a change in diagnostic criteria for patients in Hubei province, the epicenter of the outbreak.

[Comment] Contact precautions: no benefits, no indication

In view of the global increase in multidrug-resistant bacteria, applying contact precautions during the care of affected patients seems, at first, a rational approach to decrease the spread of these organisms. Increasing the distance between sources of multidrug-resistant organisms and potential recipients and using disposable equipment, such as gloves and gowns, for any contact with the patient a...


[Correspondence] Open access epidemiological data from the COVID-19 outbreak

Coronavirus disease 2019 (COVID-19) is spreading rapidly across China, and as of Feb 16, 2020, had been reported in 26 countries globally. The availability of accurate and robust epidemiological, clinical, and laboratory data early in an epidemic is important to guide public health decision-making.1 Consistent recording of epidemiological information is important to understand transmissibility, ri...

Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth

- Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications - Existing Investors Novo Holdings and RiverVest Venture Partners support the deal with new Investors HealthCap Partners, Rock Springs Capital, Aisling Capital, Surveyor Capital (a Citadel company) and Sands Capital joining the syndicate Spruce Biosciences today announced it has raised $8...

Macrolide antibiotics in pregnancy are linked with birth defects, study suggests

Children of mothers who took macrolide antibiotics during early pregnancy have shown an increased risk of major birth defects, particularly heart defects, than children of mothers who took...

Global Automotive Coolant Market Data Survey Report 20152025 [Published by HeyReport] Prices from USD $1275

SummaryAutomotive coolant, also known as antifreeze, is a liquid substance that circulates through an internal combustion engine and draws off excessive heat. The two most common chemicals used for this are ethylene and propylene glycol, both of which have lower freezing points than water 32 Fahrenheit or 0 Celsius. This allows the chemicals to flow freely even under cold winter conditions. Automo...

[Articles] Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial

We found no evidence that daily emollient during the first year of life prevents eczema in high-risk children and some evidence to suggest an increased risk of skin infections. Our study shows that families with eczema, asthma, or allergic rhinitis should not use daily emollients to try and prevent eczema in their newborn.

Storytelling, music and song: how psychosocial approaches to dementia change lives

While medicines can be an important part of dementia treatment, there are doubts over whether they provide meaningful benefits for patients. As a result, emphasis is being placed on non-pharmacological approaches, some of which have had a transformative impact on the lives of patients with dementia.

Almost 40% of hospitals do not offer non-drug therapies to distressed dementia patients

Nearly 40% of acute trusts in England do not offer any non-pharmacological therapies to help manage symptoms such as distress, aggression and agitation in patients with dementia while they are in hospital, The Pharmaceutical Journal can reveal.

Baby born from egg matured in the lab and frozen

French fertility doctors have announced what is claimed to be the first baby to be born from an immature egg that was matured in the laboratory, frozen, then thawed and fertilised years later — a breakthrough that has now been documented in the journal Annals of Oncology. Professor Michaël Grynberg, Head of the Department of Reproductive Medicine and Fertility Preservation at the Antoine Bécl...

New coronavirus spreads more like flu than SARS: Chinese study

Scientists in China who studied nose and throat swabs from 18 patients infected with the new coronavirus say it behaves much more like influenza than other closely related viruses, suggesting it may spread even more easily than previously believed. ...

Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials

A Teva Pharmaceutical drug in testing as a treatment for tics in pediatric patients with moderate-to-severe Tourette syndrome has failed two late-stage trials. Israel-based Teva (NYSE: TEVA) said Wednesday that the drug, deutetrabenazine, didn’t beat a placebo in reducing motor and phonic tics—the main goals of the Phase 2/3 and Phase 3 trials. Those signs […]

Patient satisfaction and quality of life similar across all appendicitis treatments

A new study published in the journal JAMA Surgery in February 2020 shows that patients with acute appendicitis that were successfully treated either by antibiotics or by appendectomy had identical satisfaction with their treatment and identical quality of life over the long term. The patients who were first treated conservatively and then had appendectomy had lower satisfaction rates.

Turning 80 lowers odds heart attack patients will get bypass surgery

(Reuters Health) - Age, they say, is just a number. But when someone turns 80, their chance of getting life-saving bypass surgery to treat a heart attack immediately drops by 24%, according to a new study.

Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain

SAN DIEGO, Feb. 19, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of...

Heart attack patients who were a few weeks shy of 80 were more likely to undergo heart bypass surgery than those who had just hit that milestone birthday, a new study says. https://buff.ly/2P5TNDe 

Heart attack patients who were a few weeks shy of 80 were more likely to undergo heart bypass surgery than those who had just hit that milestone birthday, a new study says. https://buff.ly/2P5TNDe 

How the psychology of a $4.99 price tag might influence who undergoes heart surgery

Heart attack patients who were a few weeks shy of 80 were more likely to undergo heart bypass surgery than those who had just hit that milestone birthday, a new…

Trefoil Therapeutics chooses @AGCBiologics, a CDMO, for the manufacture of its lead compound TTHX1114, an engineered form of FGF-1 to restore lost vision in patients with corneal diseases by regenerating corneal tissue: http://ow.ly/Gif050yqnEt pic.twit

Trefoil Therapeutics chooses @AGCBiologics, a CDMO, for the manufacture of its lead compound TTHX1114, an engineered form of FGF-1 to restore lost vision in patients with corneal diseases by regenerating corneal tissue: http://ow.ly/Gif050yqnEt  pic.twitter.com/jsklZKavRx

FDA Grants Priority Review to Selinexor for Relapsed/Refractory DLBCL

The FDA has granted a priority review designation to a supplemental new drug application for selinexor as a treatment for adult patients with relapsed/refractory diffuse large B-cell lymphoma, not otherwise specified, who have received ≥2 prior therapies.

[11C]PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder

People often skip neurological meds when out-of-pocket costs rise

(Reuters Health) - When out-of-pocket drug costs rise, patients with common neurological disorders are more likely to forgo their medication, a U.S. study suggests.

Baxter to Present at the Raymond James 41st Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 41st Annual Institutional Investors Conference in Orlando, Fla. on Monday, March 2, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:05 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be av...

Community Health Systems, Inc. Announces Fourth Quarter and Year Ended December 31, 2019 Results and 2020 Guidance

Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three months and year ended December 31, 2019. The following highlights the financial and operating results for the three months ended December 31, 2019. Net operating revenues totaled $3.286 billion. Net loss attributable to Community Health Systems, Inc. common stockhold...

Use Macrolides Cautiously in Pregnancy, Study Urges

Macrolide antibiotics carry a higher risk for major fetal malformations than penicillins when taken during pregnancy, according to a study in The BMJ. This is...


Quick Search

News Quicklinks